phase 2 study of pembrolizumab in patients with advanced rare cancers
Published 3 years ago • 24 plays • Length 2:21Download video MP4
Download video MP3
Similar videos
-
2:21
phase 2 pivotal trial of padcev in advanced urothelial cancer
-
1:54
pembrolizumab in advanced gastric cancer treatment
-
2:15
results of a first-line study of pembrolizumab in advanced urothelial cancer
-
1:23
dr. burtness on the benefit of pembrolizumab in head and neck cancer
-
3:15
pembrolizumab demonstrates promise in patients with pretreated metastatic gastric cancer
-
4:13
pembrolizumab for ps2 patients with adv. nsclc: results of the peps2 trial (bmic-067)
-
1:33
efficacy and safety results for pembrolizumab in previously treated gastric cancer
-
3:03
pembrolizumab, tumor response, and survival in advanced melanoma
-
2:05
pembrolizumab as second-line therapy for advanced urothelial carcinoma
-
1:10
pembrolizumab: a promising agent for the treatment of mm
-
7:33
pembrolizumab indication expanded, ec approves t-vec, and more
-
7:46
results from the phase 2 fast study of astellas’ investigational zolbetuximab
-
17:42
unknown primary and rare cancers
-
1:57
advanced melanoma trial when keytruda alone is not enough
-
0:42
laura chow, md discusses cross trial comparisons with keytruda and opdivo in head and neck cancers
-
9:49
rare cancers and the difficulties in making clinical decisions
-
5:37
phase iii trial shows pembrolizumab preferable to ipilimumab in advanced melanoma
-
1:54
exploring immunotherapy in patients with esophageal cancer
-
2:26
interim results for gastric cancer treatment with ramucirumab plus pembrolizumab